Literature DB >> 11593484

Low dose intravenous ketamine as an analgesic: a pilot study using an experimental model of acute pain.

D C Smith, T J Mader, H A Smithline.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11593484     DOI： 10.1053/ajem.2001.27152

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN： 0735-6757            Impact factor:   2.469


× No keyword cloud information.
  2 in total

1.  Subdissociative intranasal ketamine plus standard pain therapy versus standard pain therapy in the treatment of paediatric sickle cell disease vaso-occlusive crises in resource-limited settings: study protocol for a randomised controlled trial.

Authors:  James R Young; Hendry Robert Sawe; Juma A Mfinanga; Ernest Nshom; Ethan Helm; Charity G Moore; Michael S Runyon; Stacy L Reynolds
Journal:  BMJ Open       Date:  2017-07-10       Impact factor: 2.692

2.  Is intravenously administered, subdissociative-dose KETAmine non-inferior to MORPHine for prehospital analgesia (the KETAMORPH study): study protocol for a randomized controlled trial.

Authors:  Clément Le Cornec; Said Lariby; Vivien Brenckmann; Jean Benoit Hardouin; Claude Ecoffey; Marion Le Pottier; Philippe Fradin; Hélène Broch; Amine Kabbaj; Yannick Auffret; Florence Deciron; Céline Longo; François Javaudin; Quentin Le Bastard; Joël Jenvrin; Emmanuel Montassier
Journal:  Trials       Date:  2018-05-02       Impact factor: 2.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.